LYONS GARY A — SEC Form 4 filings

SEC reporting owner CIK 1123343. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-19.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-05-10 to 2026-08-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEUROCRINE BIOSCIENCES INC (NBIX)Director94 legs · 40,000 sh · $5,864,43220
Travere Therapeutics, Inc. (TVTX)Director68 legs · 58,000 sh · $1,550,50714

Form 4 filings — LYONS GARY A

FiledFormIssuerReported transactionsSource
2026-08-194Travere Therapeutics, Inc. (TVTX)Option exercise (M): 5,000 @ $17.44 · Sale (S): 1,900 @ $62.53 · Sale (S): 2,600 @ $63.50 · Sale (S): 500 @ $64.16 · Option exercise (M): 5,000 @ $17.44 · Sale (S): 4,100 @ $63.27 · +3 moreEDGAR
2026-05-294NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 1,284 (derivative) @ $0 · Grant/award (A): 2,624 (derivative) @ $0EDGAR
2026-05-214Travere Therapeutics, Inc. (TVTX)Grant/award (A): 4,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2026-05-214NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,659 @ $0 · Option exercise (M): 1,659 (derivative) @ $0EDGAR
2026-04-164Travere Therapeutics, Inc. (TVTX)Option exercise (M): 8,000 @ $16.33 · Sale (S): 8,000 @ $41.07 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2025-12-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 15,000 @ $47.89 · Sale (S): 15,000 @ $152.61 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-05-224NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,435 @ $0 · Grant/award (A): 1,659 (derivative) @ $0 · Grant/award (A): 3,305 (derivative) @ $0 · Option exercise (M): 1,435 (derivative) @ $0EDGAR
2025-05-164Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR
2024-10-044Travere Therapeutics, Inc. (TVTX)Option exercise (M): 40,000 @ $10.48 · Sale (S): 21,179 @ $14.35 · Sale (S): 18,821 @ $15.15 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2024-08-154NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 11,570 @ $42.76 · Sale (S): 11,570 @ $150.43 · Option exercise (M): 11,570 (derivative) @ $0EDGAR
2024-07-184NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 930 @ $42.76 · Sale (S): 930 @ $150.03 · Option exercise (M): 930 (derivative) @ $0EDGAR
2024-05-234NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 1,435 (derivative) @ $0 · Grant/award (A): 2,982 (derivative) @ $0EDGAR
2024-05-214NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,100 @ $0 · Option exercise (M): 2,100 (derivative) @ $0EDGAR
2024-05-164NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 12,500 @ $42.76 · Sale (S): 12,500 @ $135.63 · Option exercise (M): 12,500 (derivative) @ $42.76EDGAR
2024-05-104Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1123343 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →